Mandate

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").

The facility is located in Strängnäs and provides specialised expertise and comprehensive services, supporting the development and manufacturing of oral solids and with specialist infrastructure for beta-lactam production. APL, which is now acquiring the facility, is a wholly state-owned company with a social mission to develop and provide a medically appropriate and quality-assured range of extemporaneous medicines and stock preparations. The acquisition is an important step for the Swedish government in strengthening Sweden's preparedness and ensuring access to essential medicines in Sweden, particularly in crisis situations.

Read more on the Government's website here.

Vinge's team consisted of among others Jonas Bergström, Per Kling and Ellenor Eckerborn (M&A), Mathilda Persson and Siri Blomberg (Corporate Commercial), Åsa Hellstadius and Ian Jonson (Life Science).

Related

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025

Vinge advises Hallbyggarna Jonsereds in conjunction with the acquisition of Renthall

Hallbyggarna Jonsereds AB, part of the NSS Group, has acquired Renthall i Sverige AB, which has a turnover of SEK 40 million.
October 02, 2025

Vinge has advised in connection with the sale of Täby Air Maintenance AB and three Saab 2000 aircraft

Vinge has advised Erik Thun AB in connection with the sale of all shares in Täby Air Maintenance AB and three Saab 2000 aircraft to Wingefors Depå Sju AB.
October 02, 2025